Purchase Order HHSN275201800124P

<p>The National Institute of Child Health and Human Development awarded a purchase order to Illumina, Inc. for $102,585.72 on December 15, 2016, with a completion date of December 15, 2017. The order covers a comprehensive maintenance plan for HiSeq and MiSeq sequencers. Place of performance is Bethesda, Maryland. Pricing is firm fixed price.</p>

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $14,075 purchase order to Illumina, Inc. to provide services for a MiSeq high throughput sequencer. The contract has a period of performance from March 23, 2017 through April 11, 2018 and utilizes a firm fixed price payment structure. The place of performance will be in Bethesda, Maryland. This purchase order appears to be for sequencing services using...

The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $14,690 purchase order to Illumina, Inc. to provide other functions sequencing services for its HiSeq and MiSeq platforms. The services will be performed in Bethesda, Maryland over a period of approximately two months from November 8, 2016 through December 15, 2016 under a firm fixed price arrangement. No major subcontractors or set aside designations were...

The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $13,802 purchase order to Illumina, Inc. to provide other functions service agreement/product care for a MiSeq basic machine. The place of performance will be in Bethesda, Maryland. The firm fixed price contract began on February 3, 2016 and ends on March 11, 2017. The National Institute of Child Health and Human Development supports research on maternal...

<p>The National Institute of Child Health and Human Development awarded a purchase order to Illumina, Inc. for $33,197.34 on December 15, 2016, for service agreement coverage of a NextSeq sequencer and NeoPrepSystem, with final completion due November 2, 2017. Work is performed at Bethesda, Maryland. Pricing is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Child Health and Human Development issued a $5,724.24 delivery order to Illumina, Inc. on August 30, 2017, for Illumina sequencing kits.</p> <p>Place of performance is Bethesda, MD 20892. The order carries a firm fixed price and an ultimate completion date of September 2, 2020. No set-aside was used. The source does not identify a parent IDIQ or GWAC under which this delivery order was issued.</p>

<p>The National Institute of Child Health and Human Development issued a $7,642.66 delivery order to Illumina, Inc. on July 11, 2017, for an Illumina sequencing kit. Place of performance is Bethesda, MD. The order is firm fixed price with an ultimate completion date of July 9, 2018. No set-aside was used.</p>

<p>The National Institute of Child Health and Human Development issued a $117,206.18 delivery order to Illumina, Inc. on August 7, 2018, for genetic sequencing equipment and related genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of August 6, 2019. No set-aside was used.</p>

<p>The National Institute of Child Health and Human Development issued a $14,729.13 delivery order to Illumina, Inc. on July 27, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order carries a firm fixed price and was issued without set-aside designation. Ultimate completion date is August 27, 2018.</p>

<p>The National Institute of Child Health and Human Development awarded a purchase order to Illumina, Inc. valued at $13,371.24 on January 26, 2017, for genetic sequencing and genomic analysis equipment or consumables, with performance completed by March 7, 2018. Place of performance is San Diego, California. The order carries no set-aside designation and is priced on a firm fixed-price basis.</p>